The 40th Annual Miami Breast Cancer Conference

Fontainebleau Miami Beach



Date (start):

March 2, 2023

Date (end):

January 5, 2023


Fontainebleau Miami Beach


Admission Fee: 


Breast cancer represents a complicated family of diseases, and the detection, diagnosis, and multimodal management strategies of these conditions are continually evolving. As more is learned about the biology of these diseases, and with each improvement to the standards of care, new questions, challenges, and controversies arise. Therefore, practice-focused education that helps you to integrate the highest-quality management strategies into your clinic care is essential. For 39 years, the multidisciplinary Miami Breast Cancer Conference® has met this educational need by bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists to improve care for patients with breast cancer.

In March 2023, celebrating its 40th anniversary, the Miami Breast Cancer Conference® will continue this tradition of delivering the robust educational programming and top-notch presentations for which this conference is known. New for 2023 are a molecular tumor board session during the World-Class Tumor Board on Thursday, in-person radiation oncology and nursing tracks, and a poster walk with the program co-chairs and planning committee on Friday afternoon. This year’s program will also feature 2 multidisciplinary meet-the-experts challenging case discussions, lively debates, and much, much more. Register today to join us at the 40th Annual Miami Breast Cancer Conference®.

Hear it on Friday, use it on Monday.

The learning objectives of this program are:

  • Implement genomic and molecular information from validated assays as appropriate to tailor treatment planning for individual patients with breast cancer
  • Integrate evidence-based surgical and radiation approaches into multidisciplinary treatment plans to individualize care and optimize outcomes for patients with breast cancer
  • Individualize systemic therapy for patients with early-stage or advanced/metastatic breast cancer based on emerging data from clinical trials and evolving expert guidelines
  • Discuss ongoing clinical trial opportunities with novel agents or strategies that may expand treatment options for patients with breast cancer
  • Incorporate strategies for the prevention, mitigation, and management of treatment-related adverse events for patients undergoing treatment for breast cancer

This educational program is intended for medical-, surgical-, and radiation-oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.